US Stock MarketDetailed Quotes

Kura Oncology (KURA)

Watchlist
  • 9.260
  • -0.010-0.11%
Close Apr 24 15:59 ET
  • 9.280
  • +0.020+0.22%
Post 17:35 ET
821.94MMarket Cap-2.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kura Oncology (KURA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
25.24%67.48M
-67.83%17.34M
20.75M
15.29M
14.11M
53.88M
53.88M
0
0
0
Operating revenue
25.24%67.48M
-67.83%17.34M
--20.75M
--15.29M
--14.11M
--53.88M
--53.88M
--0
--0
--0
Cost of revenue
57K
0
Gross profit
25.13%67.43M
53.88M
Operating expense
50.18%371.06M
35.64%103.55M
68.24%100.75M
55.94%87.95M
44.73%78.81M
49.02%247.08M
63.25%76.34M
40.99%59.88M
41.00%56.4M
48.91%54.45M
Selling and administrative expenses
55.60%119.98M
62.60%39.14M
80.64%32.84M
50.92%25.17M
25.58%22.84M
52.49%77.11M
69.17%24.07M
38.30%18.18M
41.08%16.68M
59.87%18.18M
-General and administrative expense
55.60%119.98M
62.60%39.14M
80.64%32.84M
50.92%25.17M
25.58%22.84M
52.49%77.11M
69.17%24.07M
38.30%18.18M
41.08%16.68M
59.87%18.18M
Research and development costs
47.72%251.07M
23.23%64.41M
62.83%67.91M
58.04%62.79M
54.33%55.97M
47.50%169.97M
60.66%52.27M
42.20%41.71M
40.97%39.73M
43.97%36.27M
Operating profit
-57.16%-303.63M
-284.18%-86.27M
-33.59%-80M
-28.83%-72.67M
-18.82%-64.7M
-16.52%-193.2M
51.98%-22.46M
-40.99%-59.88M
-41.00%-56.4M
-48.91%-54.45M
Net non-operating interest income expense
18.99%25.26M
1.60%5.34M
7.32%5.88M
17.55%6.54M
52.16%7.5M
61.16%21.23M
32.19%5.26M
41.57%5.48M
96.78%5.57M
97.32%4.93M
Non-operating interest income
17.18%26.77M
0.48%5.69M
6.48%6.27M
16.11%6.94M
47.96%7.88M
55.20%22.85M
29.50%5.66M
37.82%5.89M
85.73%5.97M
86.12%5.33M
Non-operating interest expense
-6.61%1.51M
-14.14%346K
-4.61%393K
-3.69%391K
-4.02%382K
4.52%1.62M
2.28%403K
1.98%412K
4.91%406K
9.34%398K
Other net income (expense)
Income before tax
-61.88%-278.37M
-370.54%-80.93M
-36.23%-74.12M
-30.07%-66.12M
-15.50%-57.2M
-12.67%-171.97M
59.80%-17.2M
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
Income tax
-85.28%297K
-96.48%71K
0
0
226K
2.02M
2.02M
0
0
0
Net income
-60.17%-278.67M
-321.50%-81M
-36.23%-74.12M
-30.07%-66.12M
-15.96%-57.43M
-13.99%-173.98M
55.09%-19.22M
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
Net income continuous Operations
-60.17%-278.67M
-321.50%-81M
-36.23%-74.12M
-30.07%-66.12M
-15.96%-57.43M
-13.99%-173.98M
55.09%-19.22M
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
Minority interest income
Net income attributable to the parent company
-60.17%-278.67M
-321.50%-81M
-36.23%-74.12M
-30.07%-66.12M
-15.96%-57.43M
-13.99%-173.98M
55.09%-19.22M
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-60.17%-278.67M
-321.50%-81M
-36.23%-74.12M
-30.07%-66.12M
-15.96%-57.43M
-13.99%-173.98M
55.09%-19.22M
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
Basic earnings per share
-57.43%-3.18
-318.18%-0.92
-34.92%-0.85
-27.12%-0.75
-11.86%-0.66
2.88%-2.02
60.00%-0.22
-26.00%-0.63
-11.32%-0.59
-18.00%-0.59
Diluted earnings per share
-57.43%-3.18
-318.18%-0.92
-34.92%-0.85
-27.12%-0.75
-11.86%-0.66
2.88%-2.02
60.00%-0.22
-26.00%-0.63
-11.32%-0.59
-18.00%-0.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 25.24%67.48M-67.83%17.34M20.75M15.29M14.11M53.88M53.88M000
Operating revenue 25.24%67.48M-67.83%17.34M--20.75M--15.29M--14.11M--53.88M--53.88M--0--0--0
Cost of revenue 57K0
Gross profit 25.13%67.43M53.88M
Operating expense 50.18%371.06M35.64%103.55M68.24%100.75M55.94%87.95M44.73%78.81M49.02%247.08M63.25%76.34M40.99%59.88M41.00%56.4M48.91%54.45M
Selling and administrative expenses 55.60%119.98M62.60%39.14M80.64%32.84M50.92%25.17M25.58%22.84M52.49%77.11M69.17%24.07M38.30%18.18M41.08%16.68M59.87%18.18M
-General and administrative expense 55.60%119.98M62.60%39.14M80.64%32.84M50.92%25.17M25.58%22.84M52.49%77.11M69.17%24.07M38.30%18.18M41.08%16.68M59.87%18.18M
Research and development costs 47.72%251.07M23.23%64.41M62.83%67.91M58.04%62.79M54.33%55.97M47.50%169.97M60.66%52.27M42.20%41.71M40.97%39.73M43.97%36.27M
Operating profit -57.16%-303.63M-284.18%-86.27M-33.59%-80M-28.83%-72.67M-18.82%-64.7M-16.52%-193.2M51.98%-22.46M-40.99%-59.88M-41.00%-56.4M-48.91%-54.45M
Net non-operating interest income expense 18.99%25.26M1.60%5.34M7.32%5.88M17.55%6.54M52.16%7.5M61.16%21.23M32.19%5.26M41.57%5.48M96.78%5.57M97.32%4.93M
Non-operating interest income 17.18%26.77M0.48%5.69M6.48%6.27M16.11%6.94M47.96%7.88M55.20%22.85M29.50%5.66M37.82%5.89M85.73%5.97M86.12%5.33M
Non-operating interest expense -6.61%1.51M-14.14%346K-4.61%393K-3.69%391K-4.02%382K4.52%1.62M2.28%403K1.98%412K4.91%406K9.34%398K
Other net income (expense)
Income before tax -61.88%-278.37M-370.54%-80.93M-36.23%-74.12M-30.07%-66.12M-15.50%-57.2M-12.67%-171.97M59.80%-17.2M-40.94%-54.4M-36.75%-50.84M-45.37%-49.53M
Income tax -85.28%297K-96.48%71K00226K2.02M2.02M000
Net income -60.17%-278.67M-321.50%-81M-36.23%-74.12M-30.07%-66.12M-15.96%-57.43M-13.99%-173.98M55.09%-19.22M-40.94%-54.4M-36.75%-50.84M-45.37%-49.53M
Net income continuous Operations -60.17%-278.67M-321.50%-81M-36.23%-74.12M-30.07%-66.12M-15.96%-57.43M-13.99%-173.98M55.09%-19.22M-40.94%-54.4M-36.75%-50.84M-45.37%-49.53M
Minority interest income
Net income attributable to the parent company -60.17%-278.67M-321.50%-81M-36.23%-74.12M-30.07%-66.12M-15.96%-57.43M-13.99%-173.98M55.09%-19.22M-40.94%-54.4M-36.75%-50.84M-45.37%-49.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -60.17%-278.67M-321.50%-81M-36.23%-74.12M-30.07%-66.12M-15.96%-57.43M-13.99%-173.98M55.09%-19.22M-40.94%-54.4M-36.75%-50.84M-45.37%-49.53M
Basic earnings per share -57.43%-3.18-318.18%-0.92-34.92%-0.85-27.12%-0.75-11.86%-0.662.88%-2.0260.00%-0.22-26.00%-0.63-11.32%-0.59-18.00%-0.59
Diluted earnings per share -57.43%-3.18-318.18%-0.92-34.92%-0.85-27.12%-0.75-11.86%-0.662.88%-2.0260.00%-0.22-26.00%-0.63-11.32%-0.59-18.00%-0.59
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -